Jan 07,2015

MediSafe Raises $6M in Series A Funding

MediSafe, a Boston, Massachusetts-based global medication management platform, raised a $6m in Series A funding. The round was led by Pitango Venture Capital with participation from 7wire ventures, and existing investors lool Ventures, TriVentures and Eyal Gura. The company intends to use the funds to accelerate user growth in the U.S. market, expand its suite of medication management solutions, and enhance overall user experience within its mHealth apps.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Mar 05,2015

GNS Healthcare Secures $750K in Debt Financing

GNS Healthcare (Aitia) received $750K funding from the investors according to the SEC form registered.

FUNDING DEBT FINANCE
View Analyst & Ambassador Comments
Go to original news
May 26,2015

GNS Healthcare Secures $8.1M in venture round

GNS Healthcare (Aitia) received $8.1M venture funding from the investors according to the SEC form registered.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Jun 01,2015

Belong.life Raises $5 million in Series A

Tel Aviv- and New York-based Belong.Life, a startup developing a digital support network for cancer patients that uses AI to create personalized experiences, today announced that it�s raised $5 million in Series A funding round.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Dec 08,2015

GNS Healthcare Completes $10M Series C Financing

GNS Healthcare, a Cambridge, MA-based precision medicine company, completed a $10M Series C financing round. Backers included new investors Celgene Corporation, Alexandria Real Estate Equities, and Gi Global Health Fund and exiting investors Cambia Health Solutions, California�s Heritage Provider Network, and Japan�s Mitsui & Co. U.S. subsidiary. The company will use the funds to accelerate the development of new, cloud-based big data solutions at the intersection of precision medicine and population health.

FUNDING SERIES C
View Analyst & Ambassador Comments
Go to original news
Dec 11,2015

SkinIO Secures $1.5M in seed round

SkinIO received $1.5M seed funding from the investors according to the SEC form registered.

FUNDING SEED ROUND
View Analyst & Ambassador Comments
Go to original news
Jan 12,2016

Syapse Raises $25 Million Series C Round Led by Ascension Ventures to Expand Precision Medicine

Syapse, the leader in precision medicine software, has completed the first close of a $25 million Series C funding round. The financing round is being led by Ascension Ventures, a subsidiary of Ascension, the nation's largest non-profit and Catholic health system. Existing investors Social Capital Partnership and Safeguard Scientifics also participated in this new funding round.

FUNDING SERIES C
View Analyst & Ambassador Comments
Go to original news
Jan 28,2016

OncoHealth has raised $7.5M

OncoHealth Corp, a company focused on developing cancer diagnostic and treatment technologies, has raised $7.5 million USD in equity funding from two investors through a private offering of securities.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Mar 29,2016

Veracyte nabs $45M from Visium Healthcare Partners to further grow molecular diagnostics business

San Francisco-based diagnostics company, Veracyte, announced that it has brought in $45 million from healthcare investment firm Visium Healthcare Partners. This comes after it launched its IPO a few years ago. Visium is planning to spread out the funding, starting with $25 million up front, and $5 million of which will go toward paying off some of the company�s debt. After that, an additional $15 million will be available into the summer of 2017 as long as Veracyte meets some set milestones. The additional $5 million will come if the company decides to make an equity offering in the end of the time period.

FUNDING POST-IPO DEBT
View Analyst & Ambassador Comments
Go to original news
May 08,2016

Takeda Receives $38 Million Grant from the Bill & Melinda Gates Foundation to Support Polio Eradication in Developing Countries

Takeda Pharmaceutical Company Limited [TSE: 4502], (�Takeda�) today announced a partnership with the Bill & Melinda Gates Foundation to support global polio eradication in developing countries. With this funding, Takeda will develop, license and supply at least 50 million doses per year of Sabin-strain inactivated poliovirus vaccine (sIPV) to more than 70 developing countries. The vaccine will be manufactured at Takeda�s facility in Hikari, Japan. This effort is aligned with Takeda�s strategy to utilize innovation and partnerships to address critical unmet needs in global public health, and the Sustainable Development Goals adopted by the United Nations in September 2015.

FUNDING GRANT
View Analyst & Ambassador Comments
Go to original news
Subscribe to FUNDING